SCHEMBL4637764

SCHEMBL4637764

O=Cc1nnn(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)c1-c1ccncc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39
USP2 O75604 4/20 0.39
CYP3A4 P08684 4/20 0.39
TSHR P16473 3/20 0.39
HIF1A Q16665 2/20 0.39
CYP2D6 P10635 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
POLB P06746 2/20 0.36
CDC7 O00311 1/20 0.36
KIF11 P52732 1/20 0.36
S1PR1 P21453 1/20 0.34
S1PR3 Q99500 1/20 0.34
GRM2 Q14416 2/20 0.34
GPBAR1 Q8TDU6 1/20 0.34
HTT P42858 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2B Q13224 1/20 0.34
ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4638013 0.89 ALDH1A1 (0.44) HSP90AA1HSP90AB1TSHRPOLBGRM2
SCHEMBL4708361 0.85 USP2 (0.37) HSP90AA1HSP90AB1USP2CYP3A4TSHR
SCHEMBL20991166 0.81 HSP90AA1 (0.39) HSP90AA1HSP90AB1USP2CYP3A4TSHR
SCHEMBL20991111 0.81 HSP90AA1 (0.39) HSP90AA1HSP90AB1USP2CYP3A4TSHR
SCHEMBL20991107 0.81 HSP90AA1 (0.39) HSP90AA1HSP90AB1USP2CYP3A4TSHR
SCHEMBL4637749 0.80 ALDH1A1 (0.53) USP2CYP3A4TSHRHIF1ACYP2D6
Hydrochloric Acid SCHEMBL5794894 0.79 ALDH1A1 (0.52) USP2CYP3A4TSHRHIF1ACYP2D6
SCHEMBL20991106 0.79 HSP90AA1 (0.39) HSP90AA1HSP90AB1USP2CYP3A4TSHR
SCHEMBL4637981 0.79 HSP90AA1 (0.37) HSP90AA1HSP90AB1USP2CYP3A4TSHR
SCHEMBL4638624 0.77 HSP90AA1 (0.38) HSP90AA1HSP90AB1USP2CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501808-B1 TACHYKININ RECEPTOR ANTAGONISTS LILLY CO ELI (US) 2008-07-02 EP disclosed
EP-1501809-B1 TRIAZOLE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS LILLY CO ELI (US) 2008-01-16 EP disclosed
US-7179804-B2 Tachykinin receptor antagonists ELI LILLY AND COMPANY (US) 2007-02-20 US disclosed
US-20050239776-A1 Tachykinin receptor antagonists ELI LILLY AND COMPANY (US) 2005-10-27 US disclosed
EP-1501808-A1 TACHYKININ RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2005-02-02 EP disclosed
WO-2003091227-A1 TACHYKININ RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2003-11-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050239776-A1 Tachykinin receptor antagonists TACR2, TACR1, PROKR1 HSP90AA1 2154/4885HSP90AB1 2145/4885USP2 4458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.